RosTrace

Tag: TherapeuticTargets

Robin Hayes

New Biomarker Predicts Multiple Sclerosis Progression, Offering Hope for Better Treatment Strategies

Researchers at the University of Turku have identified a novel biomarker that may revolutionize how clinicians assess the progression and severity of multiple sclerosis (MS), a chronic autoimmune disease of the central nervous system. The groundbreaking study, published in Nature Medicine, offers promising new directions for both targeted treatment and faster development of therapeutic drugs—particularly for progressive MS, which remains one of the most challenging forms of the disease to treat.

· 3 min read

Robin Hayes

Early Inflammation Confirmed in Mouse Model of Hereditary Paralysis, Offering New Clues for Neurodegenerative Diseases

A groundbreaking study from the University of Bonn and the German Center for Neurodegenerative Diseases (DZNE) has revealed that inflammation in the brain may play a central role in the early progression of spastic paraplegia type 15 (SPG15), a rare hereditary neurodegenerative disorder. Conducted using a genetically modified mouse model and published in the Journal of Experimental Medicine, the research provides compelling evidence that immune system overactivation precedes neuronal degeneration—findings that may also shed light on the pathology of diseases like Alzheimer's.

· 4 min read